Pathology group sues to block FDA lab test rule

The Association for Molecular Pathology is the second lab trade group urging the courts to void an FDA policy expanding oversight of diagnostic tests.

FDA finalizes Voluntary Malfunction Summary Reporting guidance

The agency clarified when companies can submit device malfunction reports in a quarterly summary, instead of individual reports every 30 days.